These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass. Larson SP; Bowers SP; Palekar NA; Ward JA; Pulcini JP; Harrison SA Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1329-32. PubMed ID: 17702661 [TBL] [Abstract][Full Text] [Related]
4. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Takahashi Y; Fukusato T World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438 [TBL] [Abstract][Full Text] [Related]
5. High-Throughput, Machine Learning-Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease. Forlano R; Mullish BH; Giannakeas N; Maurice JB; Angkathunyakul N; Lloyd J; Tzallas AT; Tsipouras M; Yee M; Thursz MR; Goldin RD; Manousou P Clin Gastroenterol Hepatol; 2020 Aug; 18(9):2081-2090.e9. PubMed ID: 31887451 [TBL] [Abstract][Full Text] [Related]
6. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients. Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863 [TBL] [Abstract][Full Text] [Related]
8. Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials. Davison BA; Harrison SA; Cotter G; Alkhouri N; Sanyal A; Edwards C; Colca JR; Iwashita J; Koch GG; Dittrich HC J Hepatol; 2020 Dec; 73(6):1322-1332. PubMed ID: 32610115 [TBL] [Abstract][Full Text] [Related]
9. Development and Validation of a Novel Scoring System for Noninvasive Nonalcoholic Steatohepatitis Detection in Bariatric Patients. Billeter AT; Wloka S; Behnisch R; Albrecht T; Roessler S; Goeppert B; Mueller S; Nickel F; Müller B Obes Facts; 2021; 14(5):490-500. PubMed ID: 34419953 [TBL] [Abstract][Full Text] [Related]
10. qFIBS: An Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis. Liu F; Goh GB; Tiniakos D; Wee A; Leow WQ; Zhao JM; Rao HY; Wang XX; Wang Q; Wan WK; Lim KH; Romero-Gomez M; Petta S; Bugianesi E; Tan CK; Harrison SA; Anstee QM; Chang PJ; Wei L Hepatology; 2020 Jun; 71(6):1953-1966. PubMed ID: 31600834 [TBL] [Abstract][Full Text] [Related]
11. Laparoscopic Sleeve Gastrectomy on the Horizon as a Promising Treatment Modality for NAFLD. Salman MA; Salman AA; Abdelsalam A; Atallah M; Shaaban HE; El-Mikkawy A; Omar MG; Elshenoufy M Obes Surg; 2020 Jan; 30(1):87-95. PubMed ID: 31372873 [TBL] [Abstract][Full Text] [Related]
12. Bariatric Surgery in Nonalcoholic Fatty Liver Disease (NAFLD): Impact Assessment Using Paired Liver Biopsy and Fibroscan. Agarwal L; Aggarwal S; Shalimar ; Yadav R; Dattagupta S; Garg H; Agarwal S Obes Surg; 2021 Feb; 31(2):617-626. PubMed ID: 33052552 [TBL] [Abstract][Full Text] [Related]
13. Benefit-risk of intraoperative liver biopsy during bariatric surgery: review and perspectives. Barbois S; Arvieux C; Leroy V; Reche F; Stürm N; Borel AL Surg Obes Relat Dis; 2017 Oct; 13(10):1780-1786. PubMed ID: 28935200 [TBL] [Abstract][Full Text] [Related]